Is PHA.PA undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of Pharmagest Interactive SA (PHA.PA) is 48.37 EUR. This PHA.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 81.90 EUR, the upside of Pharmagest Interactive SA is -40.90%. This means that PHA.PA is overvalued by 40.90%.
The range of the Intrinsic Value is 32.59 - 96.88 EUR
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 32.59 - 96.88 | 48.37 | -40.9% |
DCF (Growth 10y) | 37.53 - 104.12 | 54.01 | -34.1% |
DCF (EBITDA 5y) | 39.40 - 47.72 | 43.53 | -46.8% |
DCF (EBITDA 10y) | 42.92 - 55.67 | 48.97 | -40.2% |
Fair Value | 22.04 - 22.04 | 22.04 | -73.08% |
P/E | 65.86 - 161.98 | 96.09 | 17.3% |
EV/EBITDA | 38.22 - 83.27 | 66.93 | -18.3% |
EPV | 19.73 - 28.27 | 24.00 | -70.7% |
DDM - Stable | 44.78 - 172.75 | 108.76 | 32.8% |
DDM - Multi | 30.18 - 87.23 | 44.46 | -45.7% |
Market Cap (mil) | 1,230.11 |
Beta | 0.58 |
Outstanding shares (mil) | 15.02 |
Enterprise Value (mil) | 1,255.23 |
Market risk premium | 5.23% |
Cost of Equity | 7.60% |
Cost of Debt | 5.00% |
WACC | 7.37% |